Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease

Bisphosphonates for postmenopausal osteoporosis

(2011) Richard Eastell et al.   BONE

The kidney and bisphosphonates

(2011) Paul D. Miller   BONE

Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis

(2011) Karen E Hansen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of Alendronate on Early Bone Loss of Renal Transplant Recipients

(2011) S. Abediazar et al.   TRANSPLANTATION PROCEEDINGS

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

Bone disease after kidney transplantation

(2008) Christa Mitterbauer et al.   TRANSPLANT INTERNATIONAL